Originally published in the April 2026 edition of Healthcare News. As artificial intelligence (AI)‑driven tools proliferate across clinical care, diagnostics, and health insurance operations, the U.S. regulatory landscape is shifting rapidly in 2026. Absent a comprehensive federal AI statute, healthcare organizations face a patchwork of federal oversight (primarily through the FDA, CMS, and HHS) layered …
Continue reading “The State of AI Regulation in Healthcare: Still Complicated”